Question from Deputy Ryan O’Meara - PQ 51755-26
Deputy O'Meara asked if a pricing and reimbursement application has been received by the HSE for zolbetuximab (vyloy). Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Meara asked if a pricing and reimbursement application has been received by the HSE for zolbetuximab (vyloy). Read the HSE response.
Deputy 0'Flynn asked about a full lifecycle cost-benefit analysis comparing long-term direct employment with agency staffing. Read the HSE response.
Deputy O'Flynn asked about the national dataset on the number of pharmacy reimbursement claims adjusted and successfully appealed. Read the HSE response.
Deputy O'Flynn asked about a dataset that records if an employee is subject to a criminal investigation or an unresolved patient-safety concern.
Deputy O'Flynn asked for an update on current waiting times for ophthalmology services. Read the HSE response.
Deputy O'Flynn asked about the number of addiction counsellors employed in CHO 4. Read the HSE response.
Deputy O'Flynn asked about the mechanism by which a pharmacy may appeal a rejected reimbursement claim. Read the HSE response.
Deputy Cummins asked about the contingency arrangements if the Dublin CervicalCheck lab experiences cyberattack, staff shortages. Read the HSE response.
Deputy Cummins asked about the percentage of all CervicalCheck samples over the past five years that have been processed in Ireland. Read the HSE response.
Deputy O'Flynn asked about the staffing budget for Cork University Maternity Hospital in 2025 and 2026. Read the HSE response.